Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
CODEXIS, INC. | Chief Financial Officer | Common Stock | 176K | $371K | $2.11 | Jan 1, 2024 | Direct |
Eiger BioPharmaceuticals, Inc. | Chief Financial Officer | Common Stock | 41.6K | $12.4K | $0.30 | Mar 14, 2022 | Direct |
CODEXIS, INC. | Chief Financial Officer | Stock Option (Right to Buy) | 314K | Jan 1, 2024 | Direct | ||
Eiger BioPharmaceuticals, Inc. | Chief Financial Officer | Stock Option (Right to Buy) | 143K | Mar 11, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CDXS | CODEXIS, INC. | Jan 1, 2024 | 2 | $0 | 4 | Jan 2, 2024 | Chief Financial Officer |
CDXS | CODEXIS, INC. | Sep 8, 2023 | 1 | $19.9K | 4 | Sep 12, 2023 | Chief Financial Officer |
CDXS | CODEXIS, INC. | Feb 10, 2023 | 2 | $0 | 4 | Feb 14, 2023 | Chief Financial Officer |
CDXS | CODEXIS, INC. | Jan 23, 2023 | 0 | $0 | 3 | Jan 25, 2023 | Chief Financial Officer |
EIGR | Eiger BioPharmaceuticals, Inc. | Mar 14, 2022 | 1 | -$12.7K | 4 | Mar 14, 2022 | Chief Financial Officer |
EIGR | Eiger BioPharmaceuticals, Inc. | Mar 11, 2022 | 2 | $0 | 4 | Mar 11, 2022 | Chief Financial Officer |
EIGR | Eiger BioPharmaceuticals, Inc. | Jul 29, 2021 | 1 | $0 | 4 | Jul 30, 2021 | Chief Financial Officer |
EIGR | Eiger BioPharmaceuticals, Inc. | May 10, 2021 | 1 | $0 | 4 | May 11, 2021 | Chief Financial Officer |